You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
Y
Recruiting
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +23 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
2021-11-29
Nov 29, 2021
N
Terminated
  • Adult Grade III Lymphomatoid Granulomatosis
  • +116 more
  • brentuximab vedotin
  • +2 more
  • Chicago, Illinois
  • +2 more
2021-08-30
Aug 30, 2021
B
Completed
  • Adult Grade III Lymphomatoid Granulomatosis
  • +88 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
2021-04-14
Apr 14, 2021
J
Recruiting
  • Relapsed Plasmablastic Lymphoma
  • +2 more
  • Belantamab Mafodotin
  • Boston, Massachusetts
  • +2 more
2021-09-20
Sep 20, 2021
B
Recruiting
  • Diffuse Large B-Cell Lymphoma
  • +14 more
  • Ann Arbor, Michigan
  • +2 more
2021-06-15
Jun 15, 2021
D
Not yet recruiting
  • Lymphoma
  • Survivorship
  • Interview with Clinicians
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
2021-10-05
Oct 5, 2021
W
Terminated
  • Follicular Lymphoma
  • Mantle Cell Lymphoma
  • New York, New York
    Weill Cornell Medicine
2021-09-20
Sep 20, 2021
U
Recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-09-07
Sep 7, 2021
M
Recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +7 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
2021-08-23
Aug 23, 2021
M
Withdrawn
  • Lymphoma
  • Home Hospital for Lymphoma
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
2021-08-31
Aug 31, 2021
N
Active, not recruiting
  • Non-Hodgkin Lymphoma
  • +4 more
  • Pembrolizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-09-02
Sep 2, 2021
A
Not yet recruiting
  • AIDS-Related Diffuse Large B-cell Lymphoma
  • +14 more
  • Axicabtagene Ciloleucel
  • +2 more
  • (no location specified)
2021-10-01
Oct 1, 2021
C
Recruiting
  • Grade 3b Follicular Lymphoma
  • +15 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
    City of Hope Medical Center
2021-01-25
Jan 25, 2021
M
Recruiting
  • Primary Mediastinal (Thymic) Large B-Cell Lymphoma
  • +10 more
  • External Beam Radiation Therapy
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
2021-05-19
May 19, 2021
D
Recruiting
  • Grade 3a Follicular Lymphoma
  • +14 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Atlanta, Georgia
  • +1 more
2021-05-13
May 13, 2021
U
Not yet recruiting
  • Non-hodgkin Lymphoma
  • +2 more
  • Radiation - Dose Level 0
  • +4 more
  • (no location specified)
2021-08-20
Aug 20, 2021
M
Active, not recruiting
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +20 more
  • Scottsdale, Arizona
  • +1 more
2021-10-06
Oct 6, 2021
M
Completed
  • Lymphoma
  • 3RP-Lymphoma
  • Boston, Massachusetts
    Massachusetts General Hospital
2021-11-09
Nov 9, 2021
M
Active, not recruiting
  • Ann Arbor Stage II Follicular Lymphoma
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-11-16
Nov 16, 2021
N
Not yet recruiting
  • Recurrent Angioimmunoblastic T-Cell Lymphoma
  • +13 more
  • Brentuximab Vedotin
  • Pembrolizumab
  • Chicago, Illinois
    Northwestern University
2021-05-06
May 6, 2021
N
Completed
  • Adult Lymphocyte Depletion Hodgkin Lymphoma
  • +19 more
  • Philadelphia, Pennsylvania
    Children's Oncology Group
2021-03-04
Mar 4, 2021
N
Active, not recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +8 more
  • Chicago, Illinois
  • +2 more
2021-08-25
Aug 25, 2021
S
Not yet recruiting
  • T-cell Lymphoma
  • +10 more
  • Chicago, Illinois
    Rush University Medical Center
2021-09-20
Sep 20, 2021
M
Recruiting
  • Aggressive Non-Hodgkin Lymphoma
  • +9 more
  • Cryosurgery
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
2021-09-03
Sep 3, 2021